Cargando…
Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
Hypercoagulability in coronavirus disease 2019 (COVID-19) may aggravate disease severity during hospitalization but the reported survival benefits from anticoagulation (AC) vary among studies. We performed a literature research to estimate pooled odds ratios (ORs) of in-hospital mortality and major...
Autores principales: | Moonla, Chatphatai, Sosothikul, Darintr, Chiasakul, Thita, Rojnuckarin, Ponlapat, Uaprasert, Noppacharn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060743/ https://www.ncbi.nlm.nih.gov/pubmed/33874753 http://dx.doi.org/10.1177/10760296211008999 |
Ejemplares similares
-
Systemic Coagulopathy in Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
por: Uaprasert, Noppacharn, et al.
Publicado: (2021) -
Bleeding Symptoms and von Willebrand Factor Levels: 30-Year Experience in a
Tertiary Care Center
por: Moonla, Chatphatai, et al.
Publicado: (2019) -
Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials
por: Uaprasert, Noppacharn, et al.
Publicado: (2021) -
Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis
por: Uaprasert, Noppacharn, et al.
Publicado: (2022) -
Heparin-induced thrombocytopenia in patients with COVID-19: a systematic review and meta-analysis
por: Uaprasert, Noppacharn, et al.
Publicado: (2021)